-
The Deerborne Group to Attend American Association for Cancer Research (AACR) Annual Meeting
SAN DIEGO, April 14, 2026 /PRNewswire/ — The Deerborne Group, a boutique consultancy focused exclusively on genomics and precision diagnostics, will attend the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17–22, 2026,
-
O’Shaughnessy Ventures Backs Scientist Building Next-Generation Artificial Muscles
Joshua Ince awarded an O’Shaughnessy Fellowship to develop low-cost, lightweight artificial muscles for robotics and prosthetics GREENWICH, Conn., April 9, 2026 /PRNewswire/ — O’Shaughnessy Ventures LLC (OSV), an investment firm that empowers creators, has awarded
-
Spirographic AI Launches First Commercial Platform to Predict Per-Transporter Drug Exposure in Fetal and Breast Milk Compartments – Achieving 96.4% and 93.7% Accuracy
The entire field predicts only whether a drug crosses — or estimates a bulk ratio. No commercial platform identifies which transporters are responsible, in which direction, or at what trimester. Spirographic AI does both —
-
Helio Genomics Appoints Experienced Healthcare Technology Executive John Doyle to its Board of Directors
Board appointment strengthens governance, innovation strategy, and long–term value creation in AI–driven early disease detection. IRVINE, Calif., April 7, 2026 /PRNewswire/ — Helio Genomics, Inc., an AI-powered TechBio company focused on early cancer detection, today
-
O’Shaughnessy Ventures Backs Researcher Bringing Clinical Trials to Patients’ Homes
Fengyi Zheng awarded an O’Shaughnessy Fellowship to replace subjective, geography-dependent motor function assessments with AI-powered home testing GREENWICH, Conn., April 2, 2026 /PRNewswire/ — O’Shaughnessy Ventures LLC (OSV), an investment firm that empowers creators, has
-
Biointelli Launches Scientific Signal Intelligence™ — A New Category That Predicts Life Science Demand Before It Exists in Your CRM
CAMBRIDGE, Mass., March 30, 2026 /PRNewswire/ — Biointelli Corporation today announced the launch of Biointelli Predict, the first commercial intelligence platform built on Scientific Signal Intelligence™ (SSI) — a new category designed to detect and score
-
Catalyst Precision Health Launches the First Longevity Service for Men to Combine In-Home Lab Testing, Physician House Calls, and Continuous Personalized Care
Catalyst is the first longevity service for men to bring in-home lab testing, physician house calls, and on-demand access to your doctor together under one model, helping men stay healthier longer through personalized protocols with
-
Stratum Biosciences Secures $2M Seed Round to Accelerate AI-Powered Skin Biology Discovery and Expanded R&D Partnerships
NEW YORK, March 27, 2026 /PRNewswire/ — Stratum Biosciences, a biotechnology pioneer at the intersection of artificial intelligence and dermatology research, announced the closing of a $2M seed funding round backed by the Harvard Business
-
Biocare Medical and Proteintech Announce Strategic Collaboration to Advance Next-Generation Antibody Technologies for Digital-Ready Pathology
The collaboration combines antibody discovery, protein engineering, and diagnostic assay expertise to support evolving pathology workflows. SAN FRANCISCO and ROSEMONT, Ill., March 23, 2026 /PRNewswire/ — Biocare Medical, a global leader in immunohistochemistry (IHC) reagents and
-
Local San Diego Latina Honored for Lifetime of Service in Accessible, Equitable Healthcare
Cindy Salas Murphy Honored for Leadership and Service SAN DIEGO, March 20, 2026 /PRNewswire/ — San Diego State University recognized alumna Cindy Salas Murphy as its 2026 Lifetime Service Honoree at its annual university commemorative scholarship
